Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Antipsychotic treatment- side effect and/or metabolic syndrome (CROSBI ID 170773)

Prilog u časopisu | prikaz, osvrt, kritika

Dadić-Hero, Elizabeta ; Ružić, Klementina ; Grahovac, Tanja ; Žarković-Palijan, Tija ; Petranović, Duška ; Šepić-Grahovac, Dubravka Antipsychotic treatment- side effect and/or metabolic syndrome // Psychiatria Danubina, 23 (2011), 1; 98-100

Podaci o odgovornosti

Dadić-Hero, Elizabeta ; Ružić, Klementina ; Grahovac, Tanja ; Žarković-Palijan, Tija ; Petranović, Duška ; Šepić-Grahovac, Dubravka

engleski

Antipsychotic treatment- side effect and/or metabolic syndrome

According to current medical opinion chronic mental diseases such as schizophrenia require life-long treatment. The choice of antipsychotics is an important treatment factor, since their side-effects often influence patients’ compliance with treatment. Severe side-effects may cause the patients to reject such treatment, the latter being their right. In case a psychiatrist does not agree with the patient’s decision to interrupt his antipsychotic treatment regardless its serious side-effects, the former should be persistent in convincing the patient to replace such drug with a more appropriate therapy.

schizophrenia; atypical antipsychotics; side effects

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

23 (1)

2011.

98-100

objavljeno

0353-5053

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost